28. Systemic amyloidosis Clinical trials / Disease details

Clinical trials : 261 /  Drugs : 276 - (DrugBank : 81) / Drug target genes : 68 - Drug target pathways : 178

  
2 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00030381
(ClinicalTrials.gov)		December 200114/2/2002Iododoxorubicin in Treating Patients With Primary Systemic AmyloidosisPhase I Trial of 4'-IODO-4'-Deoxydoxorubicin in Primary Amyloidosis (AL)Primary Systemic AmyloidosisDrug: 4'-iodo-4'-deoxydoxorubicin;Other: pharmacological studyNational Cancer Institute (NCI)NULLTerminated18 YearsN/ABoth22Phase 1United States
2NCT00003853
(ClinicalTrials.gov)		April 19991/11/19994'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic AmyloidosisPhase II Trial of 4'-IODO-4'-Deoxydoxorubicin in Primary Amyloidosis (AL)Multiple Myeloma and Plasma Cell NeoplasmDrug: 4'-iodo-4'-deoxydoxorubicinNational Cancer Institute (NCI)NULLCompleted18 YearsN/ABoth45Phase 2United States;Italy